GE HealthCare Submits New SPECT/CT System for FDA Clearance
The system is designed to support nuclear medicine imaging and the growing use of targeted radioligand therapies.
Category: Nuclear Medicine
Nuclear Medicine
Latest
Nuclear Medicine
Latest
GE HealthCare Expands Access to Cardiac PET with Flurpiridaz F 18
New tracer Flyrcado (flurpiridaz F 18)—a PET myocardial perfusion imaging (MPI) agent developed for use in patients with known or suspected CAD—gains Medicare and commercial coverage.
Nuclear Medicine
Latest
FDA OKs Siemens Healthineers SPECT/CT Scanner
Siemens Healthineers announces that the U.S. FDA has cleared the Symbia Pro.specta, an advanced SPECT/CT system that offers a low-dose CT of up to 64 slices.
Nuclear Medicine
Latest
GE HealthCare Submits New SPECT/CT System for FDA Clearance
The system is designed to support nuclear medicine imaging and the growing use of targeted radioligand therapies.
Global Nuclear Medicine to Reach $2.7 Billion by 2025
Over a stretch of the last two decades, rapid technological advancements in nuclear medicine have transformed the medicine practice, according to a new report by Grand View Research Inc. After all, with growing awareness about the importance of early diagnosis of chronic diseases, there has been a noticeable increase in diagnostic nuclear medicine procedures worldwide.
Read More
Siemens Unveils Mobile Configuration of PET/CT Scanner
Siemens Healthineers is debuting a mobile configuration of its Biograph Horizon PET/CT system at this week’s Society of Nuclear Medicine and Molecular Imaging annual conference in San Diego. The company received FDA clearance for the Biograph Horizon earlier this year.
Read More
St Louis Hospital Procures GE Healthcare SPECT/CT
Washington University School of Medicine’s Barnes-Jewish Hospital, based in St Louis, has installed GE Healthcare’s Discovery NM/CT 670 CZT SPECT/CT system—the first SPECT/CT scanner equipped with cadmium zinc telluride (CZT) technology.
Read MoreCarestream Develops PET/CT Oncology Workflow Tools
Carestream has developed oncology workflow tools for PET/CT studies on its enterprise image management system. Delivering both quantitative and qualitative information to help expedite the reading process, the new tools aid in tumor detection and tracking.
Read MoreMarket Analysts Report Increased Clinical Use of Hybrid Imaging Platforms
According to a report from market analysis company Frost & Sullivan, hybrid imaging platforms represent a significant advancement for clinicians by presenting them with both anatomical and physiological images of patients’ organs, tissues, and tumors in a single scan. Market analysts report that these platforms have widespread applications in cardiology, oncology, brain imaging, drug discovery and personalized medicine.
Read More
Open PET/CT System Improves Imaging Experience for Cancer Patients
A new cancer care center in Wisconsin recently installed the Celesteion PET/CT system from Toshiba America Medical Systems Inc to provide patients with more accurate PET/CT scans. The new Fox Valley Hematology & Oncology’s (FVHO) Health & Wellness Center, which opened in September 2015, will use the Celesteion PET/CT system to image and plan treatment for cancer patients, as well as open up a new service line in the future for orthopedic imaging.
Read More
Nuclear Medicine
Latest
Recently Launched PET/CT System Creates Super-fine, Low-dose Images
Neusoft Medical Systems Co Ltd, based in Shenyang, China, recently launched its CE-certified and FDA-approved NeuSight PET/CT system for global markets. The NeuSight PET/CT system has the capability to create super-fine and low-dose images, which can provide accurate diagnostic information with fast acquisition and post processing speeds.
